On this show hematologist and scientist Dr. Rodger Tiedemann of Ontario Cancer Institute talks about his research on myeloma relapse and its relation to progenitor cells. He also discusses best treatments for long term disease control after relapse, differences between progenitor cells and stem cells, and novel therapies that may be able to impact progenitor cells. Listen in for a more in-depth discussion on his research.